Evidence map›Paper›PMID 31749991›Full record

ReviewESMO open2019

Molecular findings reveal possible resistance mechanisms in a patient with ALK-rearranged lung cancer: a case report and literature review.

Anastasia Kougioumtzi, Panagiotis Ntellas, Eirini Papadopoulou, George Nasioulas, Eleftherios Kampletsas, George Pentheroudakis

Open access · goldAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in ESMO open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anastasia KougioumtziLaboratory of Clinical Chemistry, University of Ioannina School of Medicine, Ioannina, Greece.
Panagiotis NtellasMedical Oncology, University of Ioannina, Ioannina, Greece.
Eirini PapadopoulouDiagnostics Laboratory, GeneKor Medical SA, Athens, Greece.
George NasioulasDiagnostics Laboratory, GeneKor Medical SA, Athens, Greece.
Eleftherios KampletsasMedical Oncology, University of Ioannina, Ioannina, Greece.
George PentheroudakisMedical Oncology, University of Ioannina, Ioannina, Greece.ORCID 0000-0002-6632-2462
University of Ioannina · GRAthens Medical Center · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungDisease ProgressionDrug Resistance, NeoplasmFatal OutcomeFemaleGene RearrangementHumansLiquid BiopsyLung NeoplasmsOncogene Proteins, FusionPoint MutationProtein Kinase InhibitorsEML4-ALK fusion protein, humanOncogene Proteins, FusionProtein Kinase InhibitorsALK inhibitorsALK resistance mutationsEML4-ALK fusionmolecular profilingNon-Small-Cell Lung Cancer

Identifiers

PMID31749991
PMCPMC6830466
OpenAlexW2981845668

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.